Avoro Capital Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Avoro Capital Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,210,000	Closed	-$108M	–	53
2021 Q2	$108M	Buy	3,210,000 +260,000	+9%	+$6.63M	1.89%	15
2021 Q1	$69M	Hold	2,950,000	–	–	1.19%	18
2020 Q4	$85M	Sell	2,950,000 -1,325,000	-31%	-$33.4M	1.46%	19
2020 Q3	$86.6M	Buy	4,275,000 +275,000	+7%	+$6.71M	1.23%	18
2020 Q2	$120M	Buy	4,000,000 +350,000	+10%	+$12.6M	2.38%	14
2020 Q1	$115M	Hold	3,650,000	–	–	3.87%	10
2019 Q4	$172M	Buy	+3,650,000	New	+$105M	5.05%	6

Avoro Capital Advisors's CNST Position: Q3 2021 in Review

Avoro Capital Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 3,210,000 shares — an estimated $108M sold.

Avoro Capital Advisors first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $172M in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Avoro Capital Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Avoro Capital Advisors sold 3,210,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $108M.
Avoro Capital Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Avoro Capital Advisors's Constellation Pharmaceuticals, Inc. position peaked at $172M in Q4 2019.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Avoro Capital Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.